Skip to main content
. Author manuscript; available in PMC: 2022 Mar 4.
Published in final edited form as: Lancet Microbe. 2021 Apr 29;2(7):e320–e330. doi: 10.1016/S2666-5247(21)00044-6

Figure 1: Distribution of diagnosed drug resistance between whole-genome sequencing and local drug susceptibility testing.

Figure 1:

The categories include pan-susceptible, monoresistant (any monoresistance), multidrug-resistant, pre-XDR or XDR, any isoniazid-resistant, or any rifampicin-resistant tuberculosis. Due to rounding, some group percentage totals are more than 100%. XDR=extensively drug-resistant.